Effectiveness of Supportive Psychotherapy Through Internet-Based Teleconsultation on Psychological and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post Covid-19 Syndrome Patients
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Post-COVID-19 Syndrome
- Sponsor
- Indonesia University
- Enrollment
- 77
- Locations
- 1
- Primary Endpoint
- Pyschological and somatic symptoms
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The goal of this clinical trial is to learn about the effectiveness of supportive psychotherapy in post covid-19 syndrome patients. The main questions it aims to answer are:
- What is the effect of supportive psychotherapy on psychological and somatic symptoms in post covid-19 syndrome patients?
- What is the effect of supportive psychotherapy on the neutrophil lymphocyte ratio in post covid-19 syndrome patients?
- What is the effect of supportive psychotherapy on heart rate variability in post covid-19 syndrome patients?
Participants will be given supportive psychotherapy in the form of an online group for 3 times a week with a duration of psychotherapy ranging from 1 - 2 hours per session.
Researchers will compare the supportive psychotherapy group to education group as control. The control group will be given education about Post Covid-19 syndrome in the form of an online group for 3 times a week with a duration of around 1 - 2 hours per session.
Investigators
dr. Dika Iyona Sinulingga, SpPD
Principal Investigator
Indonesia University
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or over
- •Patients confirmed positive for SARS CoV-2 by molecular testing (SARS CoV-2 RT-PCR, naso-oropharyngeal swab) at least 3 months before recruitment, with symptoms and effects lasting for at least 2 months and not explained by alternative diagnoses other
- •Patients with or without comorbidities: diabetes mellitus, hypertension, tuberculosis, asthma, chronic obstructive pulmonary disease, chronic kidney disease, heart disease, chronic liver disease, malignancy, nervous system disease, patients with vulnerability, patients with disabilities.
- •Patients can communicate and are willing to be interviewed, fill out questionnaires and psychotherapy.
- •The patient is willing to fill out and sign an informed 1 sheet of consent to participate in the study
Exclusion Criteria
- •Psychosis
- •Can not access internet for psychotherapy
- •Not willing to take part in the research
Outcomes
Primary Outcomes
Pyschological and somatic symptoms
Time Frame: Change from baseline SCL-90 questionnaire at 1 week
Measured with SCL-90 questionnaire. Minimum score is 0, maximum score is 360. Higher scores mean worse outcome
Neutrophil Lymphocyte Ratio (NLR)
Time Frame: Change from baseline NLR at 1 week
Measured by calculating the value of the ratio of neutrophils and lymphocytes based on blood sampling
Heart Rate Variability
Time Frame: Change from baseline SDNN at 1 week
Measured by assessing SDNN by using Photoplethysmograph SA-3000P